Scott Matthew Ebert
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$6.2MFederal grants as PI8 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $6.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 23, 2026 | NIH | SBIR Phase II Development of novel therapeutics for obesity and type 2 diabetes | $1.0M | EMMYON, INC. |
| Jul 23, 2025 | NIH | SBIR Phase II Development of novel therapeutics for obesity and type 2 diabetes | $1.0M | EMMYON, INC. |
| Mar 11, 2024 | NIH | SBIR Phase II Development of novel therapeutics for cancer cachexia | $997K | EMMYON, INC. |
| Aug 30, 2021 | NIH | SBIR Phase II Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy | $745K | EMMYON, INC. |
| Sep 10, 2020 | NIH | SBIR Phase II Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy | $745K | EMMYON, INC. |
| Mar 25, 2019 | NIH | SBIR Phase II Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy | $746K | EMMYON, INC. |
| Sep 17, 2018 | NIH | SBIR Phase II Development of Novel Small Molecule Therapies for Skeletal Muscle Atrophy | $746K | EMMYON, INC. |
| Apr 1, 2016 | NIH | SBIR Phase I Discovery of Novel Pharmaceutical Agents for Skeletal Muscle Atrophy | $225K | EMMYON, INC. |
Peer ranks
Federal funding#172
Awards as PI#190
Patents#273
Companies
- EMMYON, INC.Linked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.